Banner - NPPA Connect
Logo Image

Authors

Bob Kronemyer
Latest Article

Frontline Forum Part 4: Exploring Expert Perspectives on the Management of Acne Vulgaris

In the final part of this Frontline Forum series, Neal Bhatia, MD; Dawn Eichenfield, MD, PhD; Lawrence Eichenfield, MD; Linda F. Stein Gold, MD; and Guy Webster, MD, PhD, discuss the practical and clinical considerations in the management of acne vulgaris, reviewing available treatment options and how to treat acne scars.

Patrick Krause
Latest Article

What should dermatologists do when a merger beckons?

Many dermatologists are approached by parties interested in acquiring a practice. Knowing ahead of time what questions you should ask-and how to answer their questions-can turn a simple inquiry by them into a wealth of information for you.

Joe Gorelick, MSN, FNP-C
Latest Article

New Poster: Systemic Treatment Signals Better Control in Atopic Dermatitis

Joe Gorelick, MSN, FNP-C, discusses data on systemic treatments for atopic dermatitis presented at the Derm 2025 conference.

Sarah Morgan
Latest Article

Overview from the World Congress of Pediatric Dermatology

Pediatric dermatology is a tightly knit and relatively young community. This is why the World Congress of Pediatric Dermatology, co-sponsored by the Society for Pediatric Dermatology and the American Academy of Pediatrics, is an important event for members.

Karen Appold
Latest Article

Laser treatment in children

Laser treatments can have a significant positive impact on a child’s wellbeing. Adopt techniques to minimize anxiety for children. Some conditions can be treated when the child is older.

Bill Wohnoutka
Latest Article

Childhood burn care: A telemedicine success story

One hospital leverages technology to reduce the stress of extensive, ongoing care on patients and families

Sarah Kasprowicz
Latest Article

Honey's use in skin therapy

Given the numerous types of honey and geographic variances of bee products and what is known already about honey’s use in skin therapy, it follows that there is likely untapped potential for dermatologic application, and more investigation is clearly warranted.

Daniel Mark Siegel
Latest Article

Honey's use in skin therapy

Given the numerous types of honey and geographic variances of bee products and what is known already about honey’s use in skin therapy, it follows that there is likely untapped potential for dermatologic application, and more investigation is clearly warranted.

Randy Dotinga

Randy Dotinga is a medical writer based in San Diego, Calif.

Latest Article

Sonidegib offers new option for basal cell cancer

A newly approved medication called sonidegib (Odomzo) gives physicians a second option in a class of medications designed to treat a small number of patients who suffer from locally advanced basal cell carcinoma and meet other criteria. Learn more

Reena Rupani, M.D.
Latest Article

Integrative and alternative treatments for seborrheic dermatitis

Essential oils, aloe vera, supplements, diet, and other solutions may be of use for patients who request alternative or integrative treatments for seborrheic dermatitis.

Carole C. Foos, CPA
Latest Article

Maximizing the 2-Fold Benefits of Your Charitable Donations

Many dermatologists want to donate to charity while maximizing tax benefits, and certain tools can help achieve this.

Michael Kaminer, M.D.
Latest Article

Technology advances cellulite treatment

We finally have effective interventions that address the root cause of cellulite (fibrous tethers). Now, patient education and selection becomes paramount. Long horizontal lines and the infragluteal cleft or bulge, the so-called “banana-roll” cannot be corrected with these interventions. Prior to performing cellulite procedures we must impart this knowledge to our patients to ensure realistic expectations.

Gil Yosipovitch, MD

professor and chair, department of dermatology, Director Temple Itch Center, Temple University Health System

Latest Article

Conclusions and Clinical Implications of Barzolvolimab

An expert discusses how barzolvolimab's unique mast cell-targeting mechanism, rapid efficacy, and potential disease-modifying effects position it as a promising treatment option for CSU patients who fail antihistamines or omalizumab therapy.

Robert W. McAlpine
Andrew Taylor, CFP
Latest Article

Q4 Investment Planning: What to Do Now to Reduce What You Owe in 2026

Discover 5 effective tax-saving strategies for investors in dermatology, enhancing portfolio management and planning for 2026 with OJM Group's expert insights.

Sharon A. Glick, M.D
Latest Article

Teenagers and indoor tanning

Epidemiological studies have shown a significant association between indoor tanning and melanoma. This risk especially pertains to exposure in childhood and adolescence, as these are periods of greater biological vulnerability to ultraviolet (UV) radiation.

Thomas N. King, CLU
Latest Article

YOUR ASSET PROTECTION PLAN

Was this transaction done to save taxes or did it have another economic purpose? If there was such a purpose, the transaction stands; if it was only tax-motivated, it fails.

Ilya Petrou, MD

Ilya Petrou, MD, is a contributing writer for Dermatology Times.

Latest Article

Hidradenitis Suppurativa in Transgender and Gender-Diverse Patients and Hormone Therapy

Researchers found that patients who initiated gender-affirming hormone therapy with testosterone were more likely to experience a worsening of their HS symptoms.

Staff reports
Latest Article

Favorable Safety, Efficacy Data on Newer Acne Vulgaris Treatment

Clascoterone cream 1% phase 3 results presented at meeting.

Tracey Walker
Latest Article

FDA approves luliconazole for tinea pedis

The Food and Drug Administration has approved luliconazole (Luzu Cream, 1 percent, Valeant Pharmaceuticals) for the two-week, once-daily treatment of interdigital tinea pedis, tinea cruris, and tinea corporis, caused by the organisms Trichophyton rubrum and Epidermophyton floccosum, in patients ages 18 and older.

Marie Rosenthal
Latest Article

Early intervention curbs atopic dermatitis in children

Early initiation of treatment for atopic dermatitis (AD) offers the best possibility for altering the natural course of the disease, increasing the odds that children might outgrow the problem, according to Elaine Siegfried, M.D., professor of pediatrics in dermatology, Saint Louis University Health Sciences Center, St. Louis.

Robb Marchione, M.D.
Latest Article

Noninvasive devices for lifting, tightening gaining momentum

New devices are hitting the market with claims of skin-tightening capabilities.

Lisa Grunebaum, M.D.
Latest Article

Noninvasive devices for lifting, tightening gaining momentum

New devices are hitting the market with claims of skin-tightening capabilities.

Diane Donofrio Angelucci
Latest Article

Dermatologic conditions can affect the mind, and vice versa

Although dermatologic conditions most apparently affect the skin, dermatologists commonly encounter three types of psychodermatologic disorders where the mind and skin may interact, according to John Koo, M.D., professor and vice chairman, department of dermatology, University of California, San Francisco Medical Center.

Gary N. Fox, M.D.
Latest Article

Letter to the editor: Checks,balances: Where should the pharmacist's loyalty lie?

Norman Levine, M.D., as evidenced in his Sep. 1, 2008, Dermatology Times Commentary (Commentary: Pharmacists, insurers limit scope of practice, prescription choices) is an articulate, caring and excellent physician, and I commend him for taking care of patients with delusions of parasitosis, a disease many of his colleagues elect to refer.

Terry Allman, C.P.C., Q.P.A., Q.K.A., C.R.P.C.
Latest Article

What's new in retirement planning?

Defined benefit pension plans as well as cash balance plans are generating a lot of interest with medical practices, both large and small.

Joely Kaufmann
Latest Article

A close look at best use, technique, history of the ruby

Literature review, best use, techniques for the ruby laser.

Kathleen Steele Gaivin
Latest Article

Bringing up baby: Pediatric subspecialty recent marker for dermatology

The certification of pediatric dermatology as a subspecialty is a relatively recent milestone in the field of dermatology.

Wayne Kuznar
Latest Article

Dupilumab tames AD in difficult-to-treat patients

Dupilumab given concomitantly with topical corticosteroids significantly improved signs and symptoms of atopic dermatitis (AD) in adults refractory to or intolerant of cyclosporine A, a study shows.

Brian L. Baker, M.D., F.A.A.D.
Latest Article

Challenging AAD: Doctor disagrees on House bill 3200

I was dismayed to learn that the elite leadership of the American Academy of Dermatology has hastily supported House Bill 3200.